Log In
BCIQ
Print this Print this
 

HyStem ReGlyde

  Manage Alerts
Collapse Summary General Information
Company BioTime Inc.
DescriptionCross-linked thiol-modified hyaluronan hydrogel based on HyStem technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentDiscovery
Standard IndicationTissue damage
Indication DetailsProtect tendon injuries following surgical repair of digital flexor or extensor tendons of the hand
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today